Literature DB >> 8462022

Clinical results with recombinant human interleukin-3.

A Ganser1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1993        PMID： 8462022     DOI： 10.3109/07357909309024841

Source DB:  PubMed          Journal:  Cancer Invest        ISSN： 0735-7907            Impact factor:   2.176


× No keyword cloud information.
  1 in total

1.  Potent interleukin 3 receptor agonist with selectively enhanced hematopoietic activity relative to recombinant human interleukin 3.

Authors:  J W Thomas; C M Baum; W F Hood; B Klein; J B Monahan; K Paik; N Staten; M Abrams; J P McKearn
Journal:  Proc Natl Acad Sci U S A       Date:  1995-04-25       Impact factor: 11.205
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.